PEGylation of a glycosaminoglycan-binding, dominant-negative CXCL8 mutant retains bioactivity in vitro and in vivo

Cytokine - Tập 127 - Trang 154942 - 2020
T. Gerlza1,2, C. Trojacher1,2, D. Jeremic2, E. Krieger3, T. Adage2, A. Kungl1,2
1Karl-Franzens-University Graz, Schubertstrasse 1, 8010 Graz, Austria
2ProtAffin Biotechnology AG, Reininghausstrasse 13a, 8020 Graz, Austria
3YASARA Biosciences GmbH & CMBI, Wagramer Strasse 25/3/45, 1220 Vienna, Austria

Tài liệu tham khảo